Revalia Bio is transforming loss of a loved one into profound change in the world. We believe that organ donation for groundbreaking research holds the key to revolutionizing biomedical innovation. Because every donated organ provides a window into human health and disease that can unlock the rapid development of major medical breakthroughs.
Location: United States
Total raised: $14.5M
Investors 2
| Date | Name | Website |
| - | Connecticu... | ctinnovati... |
| - | Leva Capit... | levacapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.09.2025 | Seed | $14.5M | Sierra Ven... |
Mentions in press and media 3
| Date | Title | Description |
| 05.09.2025 | Revalia Bio Launches ‘Human Data Trials’ with $14.5M to Transform Drug Development | What You Should Know: – Revalia Bio Inc., a new pre-clinical research company secures $14.5M in seed funding round to support the launch of its “Human Data Trials”. – The funding was co-led by America’s Frontier Fund and Sierra Ventures, wi... |
| - | Revalia Bio | “Revalia Bio enables faster, safer drug development with Human Data Trials—delivering real human data before clinical trials begin.” |
| - | Revalia Bio | “Revalia” |